gerd glp 1 For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research presented at the GERD and Weight Loss Medication:

doi:10.1038/s41401-020-0413-7

Timestamped Show Notes [00:00:00] Introduction - Brittany's home office with plants and dogs [02:02] The "holistic" medicine debate [04:02] Why Brittany opened Sweetgrass Psychiatry [07:00] Bringing family medicine in-house [10:01] The economics of integrating primary care [11:08] Scaling to 30 clinicians [13:41] Full suite of interventional services offered [15:08] Nine out of twenty patients on GLP-1s [16:15] Depression and metabolic syndrome: 50/50 overlap [19:03] GLP-1s and the mesolimbic system [20:24] JAMA Psychiatry study on semaglutide for alcohol use disorder [21:17] Dr

The use of Vitamin B12 supplements in cancer patients undergoing chemotherapy is a complex issue, requiring careful consideration of the benefits and risks. Dr

The supernatant was collected after centrifugation and protein content was determined